BARDA’s Project BioShield purchased $37 million worth of the antibiotic to support national preparedness.
The report comes as emerging infectious diseases such as COVID-19, H5N1 avian influenza, and measles challenge public health systems.
But some experts say it will impede the US’s ability to address infectious disease threats and respond to outbreaks.
Sean Kaufman's skepticism of vaccines may be too fringe for the Louisiana senator, whose support is crucial for confirmation.
A multiyear budget asks for $53 billion over the next 3 fiscal years.
The nominee for assistant secretary for preparedness and response has a track record of vaccine skepticism.
Outbreaks are linked to operational failures, lab settings, and personnel type, while not inactivating pathogens is strongly tied to mortality.
HHS should make more information public about how it mitigates risks for experiments that make pathogens more transmissible or virulent, a new report says.
Experts say the move will hobble the United States’ ability to respond to future infectious disease threats.
Japan’s guidance didn’t share any of the 10 key components with the US, while Canada had all 10, with wide variation in the remaining nations.
